Hungary to remove device non-tariff barrier this year?
This article was originally published in Clinica
Manufacturers outside the EU who have CE-marked medical devices may be able, by the end of 2003, to enter for the first time the Hungarian market without the need for additional approval of their products by the Hungarian authorities. If not, they will have to wait until May 2004, when Hungary joins the EU, to benefit from free trade with the country.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.